AbbVie Inc

NYSE : ABBV
USA·Healthcare·Drug Manufacturers·Ordinary Shares
$285.42
−1.36 (−0.54%)Oct 16 close
Market Cap
$504.37B
Enterprise Value
$568.67B
P/E (TTM)
80.63
P/B
—
Net Cash / (Debt)
−$64.25B
52-Week Range
$197 — $285
5-Year Range
$107 — $285
Avg Volume (3M)
6.69M
ListingsNYSELTSXTER

Curated managers

7 of 57 hold AbbVie Inc · holdings at Jun 30, 2026

Manager% of bookChange
Glenview Capital Management, LLC
Larry Robbins · Chief Investment Officer
0.75%New position+148.9K
New England Asset Management, Inc.0.70%Added+160
Horizon Kinetics Asset Management LLC
Murray Stahl · Co-Founder, Chairman, CEO & CIO (died 2026-04-07) (historical)
0.05%Reduced-322
Gardner Russo & Quinn LLC
Thomas Russo · Managing Member/Chairman
0.03%Unchanged
Bridgewater Associates, LP
Ray Dalio · Founder (relinquished control of the firm in 2022) (historical)
0.01%Reduced-18.6K
Dodge & Cox0.00%Unchanged
Harris Associates L.P. (Oakmark Funds)
Bill Nygren · Partner and Co-CIO, U.S.
0.00%Reduced-262
Baron Capital Group (BAMCO, Inc.)
Ron Baron · Founder, Chief Executive Officer and Portfolio Manager
—Sold out